What is Green Planet Bioengineering Co's earnings per share (EPS)?

Green Planet Bioengineering Co (GPLB) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Green Planet Bioengineering Co Financials

GPLB

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE March

This page shows Green Planet Bioengineering Co (GPLB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Low Quality

1.02x

For every $1 of reported earnings, Green Planet Bioengineering Co generates $1.02 in operating cash flow (-$37K OCF vs -$36K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

-$36K

YoY-0.8%

Green Planet Bioengineering Co reported -$36K in net income in fiscal year 2025. This represents a decrease of 0.8% from the prior year.

EPS (Diluted)

$0.00

Green Planet Bioengineering Co earned $0.00 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

20M

YoY+0.0%

5Y CAGR+0.0%

10Y CAGR+0.0%

Green Planet Bioengineering Co had 20M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

GPLB Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$36K+0.8%	$36K-25.0%	$47K+45.6%	$33K-1.2%	$33K-2.0%	$34K
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	$0-100.0%	$300	$0	N/A	N/A
Income Tax	N/A	$0	$0	$0	$0	$0
Net Income	-$36K-0.8%	-$36K+25.4%	-$48K-46.5%	-$33K+1.2%	-$33K+2.0%	-$34K
EPS (Diluted)	$0.00	$0.00	$0.00	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$9K+109.5%	$4K-40.0%	$7K	N/A	$5K-50.1%	$11K+68.0%	$6K	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$0	$0	$0	N/A	$0	$0	$0	N/A
Net Income	-$9K-109.5%	-$4K+40.0%	-$7K	N/A	-$5K+50.1%	-$11K-68.0%	-$6K	N/A
EPS (Diluted)	$0.00	$0.00	$0.00	N/A	$0.00	$0.00	$0.00	N/A

GPLB Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	N/A	N/A	N/A	N/A	N/A	N/A
Current Assets	N/A	$0	$0	$0	$0	$0
Cash & Equivalents	N/A	$0	$0	$0	$0	$0
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Current Liabilities	N/A	$465K+8.3%	$430K+12.5%	$382K+9.3%	$349K+10.4%	$316K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	N/A	-$465K-8.3%	-$430K-12.5%	-$382K-9.3%	-$349K-10.4%	-$316K
Retained Earnings	N/A	-$1.1M-3.4%	-$1.1M-4.7%	-$1.0M-3.3%	-$979K-3.5%	-$946K

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Assets	$0	$0	$0	$0	$0	$0	$0	$0
Cash & Equivalents	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Liabilities	$485K+1.8%	$476K+0.9%	$472K+1.5%	$465K+2.8%	$452K+1.2%	$447K+2.5%	$436K+1.5%	$430K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$485K-1.8%	-$476K-0.9%	-$472K-1.5%	-$465K-2.8%	-$452K-1.2%	-$447K-2.5%	-$436K-1.5%	-$430K
Retained Earnings	-$1.1M-0.8%	-$1.1M-0.4%	-$1.1M-0.6%	-$1.1M-1.2%	-$1.1M0.0%	-$1.1M-1.5%	-$1.1M-0.6%	-$1.1M

GPLB Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$37K-4.3%	-$35K+17.9%	-$43K-31.2%	-$33K+1.2%	-$33K+2.6%	-$34K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	$35K-17.9%	$43K	$0	N/A	N/A
Financing Cash Flow	$37K	N/A	$43K+31.2%	$33K-1.2%	$33K-2.6%	$34K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$7K-8.9%	-$6K+12.8%	-$7K+38.8%	-$11K-108.1%	-$5K+47.7%	-$10K-30.1%	-$8K+36.5%	-$13K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$0	$0	$0-100.0%	$35K	$0	$0	$0-100.0%	$43K
Financing Cash Flow	$7K+8.9%	$6K-12.8%	$7K	N/A	$5K-47.7%	$10K+30.1%	$8K-36.5%	$13K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

GPLB Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	0.000.0	0.000.0	0.000.0	0.000.0	0.00
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	0.000.0	0.000.0	0.000.0	0.000.0	0.000.0	0.000.0	0.000.0	0.00
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

Is Green Planet Bioengineering Co profitable?

No, Green Planet Bioengineering Co (GPLB) reported a net income of -$36K in fiscal year 2025.

What is Green Planet Bioengineering Co's operating cash flow?

Green Planet Bioengineering Co (GPLB) generated -$37K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

How many shares does Green Planet Bioengineering Co have outstanding?

Green Planet Bioengineering Co (GPLB) had 20M shares outstanding as of fiscal year 2025.

Are Green Planet Bioengineering Co's earnings high quality?

Green Planet Bioengineering Co (GPLB) has an earnings quality ratio of 1.02x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.